Ex Parte Hensbergen et al - Page 5


               Appeal 2007-0941                                                                             
               Application 10/165,068                                                                       
               performed within personal computer 20 (fig. 1).  The Examiner further                        
               argues that Appellants have mistakenly drawn the conclusion that network                     
               interface 53 of Gbadegesin is the only network controller disclosed.  The                    
               Examiner points out that the term “network controller” is not so limited                     
               considering the breadth of Appellants’ Specification that discloses: “the                    
               network controller may be an intelligent peripheral installed within a server                
               or may be a network processor (NP) coupled to a server” (Specification 4:5-                  
               7).  The Examiner concludes that Appellants have mischaracterized                            
               Gbadegesin's fig. 11 by stating that the gNAT function is performed by                       
               server 140 (emphasis added).  In contrast, the Examiner notes that gNAT                      
               140 is a gateway machine, and is not a server, such as servers S1-S4 (fig. 11,               
               col. 10, ll. 5-6). The Examiner concludes that the gNAT (kernel-mode                         
               translation module), is not located at the server or client, but at the gateway              
               (e.g. network controller) coupled between the servers and the clients, as                    
               shown in fig. 11 (Answer 15-17).                                                             
                      In rejecting claims under 35 U.S.C. § 102, a single prior art reference               
               that discloses, either expressly or inherently, each limitation of a claim                   
               invalidates that claim by anticipation.  Perricone v. Medicis Pharmaceutical                 
               Corp., 432 F.3d 1368, 1375-76, 77 USPQ2d 1321, 1325-26 (Fed. Cir. 2005)                      
               (citing Minn. Mining & Mfg. Co. v. Johnson & Johnson Orthopaedics, Inc.,                     
               976 F.2d 1559, 1565, 24 USPQ2d 1321, 1326 (Fed. Cir. 1992)).                                 
               Anticipation of a patent claim requires a finding that the claim at issue                    
               “reads on” a prior art reference.  Atlas Powder Co. v. IRECO, Inc., 190 F.3d                 
               1342, 1346, 51 USPQ2d 1943, 1945 (Fed. Cir. 1999) (“In other words, if                       
               granting patent protection on the disputed claim would allow the patentee to                 


                                                     5                                                      

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next

Last modified: September 9, 2013